- Report
- June 2024
- 200 Pages
Global
From €7535EUR$7,950USD£6,295GBP
The Lumbar Disc Disease Drug market is a subset of the larger Musculoskeletal Disorders Drugs market. These drugs are used to treat lumbar disc disease, a condition that affects the discs between the vertebrae in the lower back. Symptoms of lumbar disc disease can include pain, numbness, and weakness in the lower back and legs. Treatment options for lumbar disc disease include physical therapy, medications, and surgery.
Drugs used to treat lumbar disc disease include non-steroidal anti-inflammatory drugs (NSAIDs), muscle relaxants, and opioids. NSAIDs are used to reduce inflammation and pain, while muscle relaxants are used to reduce muscle spasms. Opioids are used to reduce pain, but they can be addictive and have other side effects.
Some companies in the Lumbar Disc Disease Drug market include Pfizer, Merck, and Novartis. These companies produce a variety of drugs used to treat lumbar disc disease, including NSAIDs, muscle relaxants, and opioids. Show Less Read more